The creed of investing?
NWBO has the opportunity to save many cancer patients with nGBM, rGBM and other cancers as well.
The latest results from Dr. Linda Liau's research presentations, it appears that when DCVax-L is combined with other compounds can address multiple cancers.
In other words, DCVax-L should be able to address multiple cancers in both humans and could also address potentially animals as well.
Looking at the big picture, I have creating multiple S-Curves based on advanced business marketing and sales models, NWBO could be worth $$$ billions in a relatively short period of time, 2-3 years.
The good news is that NWBO has establish a vast array of patents and is considered one of the leading pioneers in the biotherapy research.
You can sell at $10, but my research indicates a potential of 5X, to 25X this price and not too far in the future.
Market Data 
Markets 
